Tackling step therapy, formulary changes
Too often, step therapy protocols interfere with your patients’ care and create unwanted burdens on your practice.
Thanks to the AADA’s advocacy efforts, dozens of states have enacted step therapy reform laws, recognizing the value of a physician’s medical judgment. Most recently, our work resulted in strengthening the existing step therapy law in Kentucky.
Similarly, we worked with the Oregon Dermatology Society to oppose language in an Oregon Medicaid policy that would have created a closed formulary for adult Medicaid patients — providing broad discretion to the state as to whether a drug has “limited or inadequate evidence of clinical efficacy.” Thanks to our advocacy efforts, this closed formulary language was removed from the proposal.